1,266
Views
6
CrossRef citations to date
0
Altmetric
Research Paper

Etomidate ameliorated advanced glycation end-products (AGEs)-induced reduction of extracellular matrix genes expression in chondrocytes

, , , ORCID Icon &
Pages 4191-4200 | Received 31 Mar 2021, Accepted 30 Jun 2021, Published online: 24 Jul 2021

References

  • Carr AJ, Robertsson O, Graves S, et al. Knee replacement. Lancet. 2012;379:1331–1340.
  • Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheumatism. 2008;58:26–35.
  • Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet. 2011;377:2115–2126.
  • Loeser RF. Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix. Osteoarthritis Cartilage. 2009;17:971–979.
  • Wang M, Shen J, Jin H, et al. Recent progress in understanding molecular mechanisms of cartilage degeneration during osteoarthritis. Ann NY Acad Sci. 2011;1240:61–69.
  • Houard X, Goldring MB, Berenbaum F. Homeostatic mechanisms in articular cartilage and role of inflammation in osteoarthritis. Curr Rheumatol Rep. 2013;15:375.
  • Pacifici M, Koyama E, Iwamoto M, et al. Development of articular cartilage: what do we know about it and how may it occur? Connect Tissue Res. 2000;41:175–184.
  • Knudson CB, Knudson W. Cartilage proteoglycans. Semin Cell Dev Biol. 2001;12:69–78.
  • Eyre D. Collagen of articular cartilage. Arthritis Res. 2002;4:30–35.
  • Saudek DM, Kay J. Advanced glycation endproducts and osteoarthritis. Curr Rheumatol Rep. 2003;5:33–40.
  • Li NG, Shi ZH, Tang YP, et al. New hope for the treatment of osteoarthritis through selective inhibition of MMP-13. Curr Med Chem. 2011;18:977–1001.
  • Bi W, Deng JM, Zhang Z, et al. Sox9 is required for cartilage formation. Nat Genet. 1999;22:85–89.
  • Lee JS, Im GI. SOX trio decrease in the articular cartilage with the advancement of osteoarthritis. Connect Tissue Res. 2011;52:496–502.
  • Lefebvre V, Huang W, Harley VR, et al. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol. 1997;17:2336–2346.
  • Bell DM, Leung KK, Wheatley SC, et al. SOX9 directly regulates the type-II collagen gene. Nat Genet. 1997;16:174–178.
  • Wang L, Mi B, Zhang Y, et al. Alendronate promotes the gene expression of extracellular matrix mediated by SP-1/SOX-9. Hum Exp Toxicol. 2021;;40(7):1173–1182.
  • Hulsman N, Hollmann MW, Preckel B. Newer propofol, ketamine, and etomidate derivatives and delivery systems relevant to anesthesia practice. Best Pract Res Clin Anaesth. 2018;32:213–221.
  • Morgan M, Lumley J, Whitwam JG. Etomidate, a new water-soluble non-barbiturate intravenous induction agent. Lancet. 1975;1:955–956.
  • Schmucker AC, Wright JB, Cole MD, et al. Distal interleukin-1β (IL-1β) response element of human matrix metalloproteinase-13 (MMP-13) binds activator protein 1 (AP-1) transcription factors and regulates gene expression. J Biol Chem. 2011;287:1189–1197.
  • Liu M, Zhang Y, Xiong JY, et al. Etomidate mitigates lipopolysaccharide-induced CD14 and TREM-1 expression, NF-κB activation, and pro-inflammatory cytokine production in rat macrophages. Inflammation. 2016;39:327–335.
  • Brohan J, Goudra BG. The role of GABA receptor agonists in anesthesia and sedation. CNS Drugs. 2017;31:845–856.
  • Nong AN, Li QF, Huang ZJ, et al. MicroRNA miR-126 attenuates brain injury in septic rats via NF-κB signaling pathway. Bioengineered. 2021;12:2639–2648.
  • Wang SC, Li P, Jiang G, et al. Long non-coding RNA LOC285194 inhibits proliferation and migration but promoted apoptosis in vascular smooth muscle cells via targeting miR-211/PUMA and TGF-β1/S100A4 signal. Bioengineered. 2020;11:718–728.
  • Tong L, Tang CX, Cai CJ, et al. Upregulation of the microRNA rno-miR-146b-5p may be involved in the development of intestinal injury through inhibition of Kruppel-like factor 4 in intestinal sepsis. Bioengineered. 2020;11:1334–1349.
  • Schmidt AM, Yan SD, Stern DM. The dark side of glucose. Nat Med. 1995;1:1002–1004.
  • Reiser KM. Nonenzymatic glycation of collagen in aging and diabetes. Proc Soc Exp Biol Med. 1991;196:17–29.
  • Sell DR, Monnier VM. Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J Biol Chem. 1989;264:21597–21602.
  • DeGroot J, Verzijl N, Wenting-van Wijk MJ, et al. Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis. Arthritis Rheum. 2004;50:1207–1215.
  • Steenvoorden MM, Huizinga TW, Verzijl N, et al. Activation of receptor for advanced glycation end products in osteoarthritis leads to increased stimulation of chondrocytes and synoviocytes. Arthritis Rheum. 2006;54:253–263.
  • Hipkiss AR. Energy metabolism, altered proteins, sirtuins and ageing: converging mechanisms? Biogerontology. 2008;9:49–55.
  • Nah SS, Choi IY, Yoo B, et al. Advanced glycation end products increases matrix metalloproteinase-1, −3, and −13, and TNF-alpha in human osteoarthritic chondrocytes. FEBS Lett. 2007;581:1928–1932.
  • Im GI, Kim HJ, Lee JH. Chondrogenesis of adipose stem cells in a porous PLGA scaffold impregnated with plasmid DNA containing SOX trio (SOX-5,-6 and −9) genes. Biomaterials. 2011;32:4385–4392.
  • Lee JM, Im GI. SOX trio-co-transduced adipose stem cells in fibrin gel to enhance cartilage repair and delay the progression of osteoarthritis in the rat. Biomaterials. 2012;33:2016–2024.
  • Cucchiarini M, Orth P, Madry H. Direct rAAV SOX9 administration for durable articular cartilage repair with delayed terminal differentiation and hypertrophy in vivo. J Mol Med (Berl). 2013;91:625–636.
  • Lefebvre V, Smits P. Transcriptional control of chondrocyte fate and differentiation. Birth Defects Res C Embryo Today. 2005;75:200–212.
  • De Crombrugghe B, Lefebvre V, Behringer RR, et al. Transcriptional mechanisms of chondrocyte differentiation. Matrix Biol. 2000;19:389–394.
  • Shi JM, Cao FY, Chang YJ, et al. Long non-coding RNA MCM3AP-AS1 protects chondrocytes ATDC5 and CHON-001 from IL-1β-induced inflammation via regulating miR-138-5p/SIRT1. Bioengineered. 2021;12:1445–1456.
  • Wang H, Jiang Z, Pang Z, et al. Engeletin protects against TNF-α-induced apoptosis and reactive oxygen species generation in chondrocytes and alleviates osteoarthritis in vivo. J Inflamm Res. 2021;14:745–760.
  • Brett J, Schmidt AM, Yan SD, et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol. 1993;143:1699–1712.
  • Clancy R, Rediske J, Koehne C, et al. Activation of stress-activated protein kinase in osteoarthritic cartilage: evidence for nitric oxide dependence. Osteoarthritis Cartilage. 2001;9:294–299.
  • Mengshol JA, Vincenti MP, Coon CI, et al. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor κB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum. 2000;43:801–811.
  • Sacitharan PK. Ageing and osteoarthritis. Subcell Biochem. 2019;91:123–159.
  • Cherfan AJ, Arabi YM, Al-Dorzi HM, et al. Advantages and disadvantages of etomidate use for intubation of patients with sepsis. Pharmacotherapy. 2012;32(5):475–482.